Journal
PULMONARY CIRCULATION
Volume 3, Issue 2, Pages 315-328Publisher
SAGE PUBLICATIONS INC
DOI: 10.4103/2045-8932.114758
Keywords
asthma; COPD; cystic fibrosis; microRNA; pulmonary arterial hypertension; pulmonary development; pulmonary disease
Funding
- National Institute of Health [HL093154, HL108317]
- American Heart Association [0940095N]
- LeDucq foundation Transatlantic network grant
Ask authors/readers for more resources
MicroRNAs (miRNAs) are a class of small noncoding RNA which exert post- transcriptional gene regulation activity by targeting messenger RNAs. miRNAs have been found to be involved in various fundamental biological processes and deregulation of miRNAs is known to result in pathological conditions. In this review, we provide an overview of recent discoveries on the role played by this class of molecules in lung development and in pulmonary diseases, such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and pulmonary artery hypertension. Considering the relevant role of these miRNAs under physiological and pathological conditions, they represent new clinical targets as well as diagnostic and prognostic tools. Therefore, this review pays special attention to recent advances and possible future directions for the use of miRNAs for clinical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available